Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health (2026)
Chapter: Appendix G: Pediatric Representation on Scientific Review
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix F: NIH Pediatric Research Consortium Agenda Items
Appendix G
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Appendix G
Pediatric Representation on Scientific Review
TABLE G-1 Pediatric Representation Within NIH Study Sections, as of April 24, 2025
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Reproductive, Perinatal, and Pediatric Health | 20 | 9 | 45% |
| Advancing Therapeutics-B | 9 | 3 | 33% |
| Developmental Brain Disorders | 23 | 7 | 30% |
| Human Studies of Diabetes and Obesity | 18 | 5 | 28% |
| Immunobiology of Transplantation and Alloimmunity | 15 | 4 | 27% |
| Lung Immunology and Infection | 16 | 4 | 25% |
| Neurogenesis and Cell Fate | 16 | 4 | 25% |
| Pregnancy and Neonatology | 20 | 5 | 25% |
| Basic Biology of Blood, Heart and Vasculature | 21 | 5 | 24% |
| Psychosocial Development, Risk, and Prevention | 21 | 5 | 24% |
| Molecular and Structural Immunology | 17 | 4 | 24% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Therapeutic Approaches to Genetic Diseases | 17 | 4 | 24% |
| Population-Based Research in Infectious Disease | 13 | 3 | 23% |
| Cancer and Hematologic Disorders | 17 | 3 | 18% |
| Child Psychopathology and Developmental Disabilities | 23 | 4 | 17% |
| Digestive and Nutrient Physiology and Diseases | 18 | 3 | 17% |
| Nutrition and Metabolism in Health and Disease | 18 | 3 | 17% |
| Surgery, Anesthesiology, and Trauma | 24 | 4 | 17% |
| Digestive System Host Defense, Microbial Interactions, and Immune and Inflammatory Diseases | 19 | 3 | 16% |
| Interdisciplinary Clinical Care in Specialty Care Settings | 19 | 3 | 16% |
| Innate Immunity B | 19 | 3 | 16% |
| Hemostasis, Thrombosis, Blood Cells, and Transfusion | 20 | 3 | 15% |
| Mechanisms of Cancer Therapeutics B | 20 | 3 | 15% |
| Pathobiology of Kidney Disease | 20 | 3 | 15% |
| Addiction Risks and Mechanisms | 14 | 2 | 14% |
| Development - 1 | 7 | 1 | 14% |
| Interspecies Microbial Interactions and Infections | 15 | 2 | 13% |
| Clinical Neuroimmunology and Brain Tumors | 23 | 3 | 13% |
| Basic Mechanisms of Diabetes and Metabolism | 16 | 2 | 13% |
| Pulmonary Injury Remodeling and Repair | 17 | 2 | 12% |
| Genetics of Health and Disease | 26 | 3 | 12% |
| Cell Signaling and Molecular Endocrinology | 18 | 2 | 11% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| HIV Comorbidities and Clinical Studies | 18 | 2 | 11% |
| Kidney and Urological Systems Function and Dysfunction | 18 | 2 | 11% |
| Viral Dynamics and Transmission | 18 | 2 | 11% |
| Atherosclerosis and Vascular Inflammation | 19 | 2 | 11% |
| Clinical Informatics and Digital Health | 19 | 2 | 11% |
| Lifestyle Change and Behavioral Health | 19 | 2 | 11% |
| Science of Implementation in Health and Healthcare | 19 | 2 | 11% |
| Bacterial–Host Interactions | 20 | 2 | 10% |
| Biobehavioral Medicine and Health Outcomes | 20 | 2 | 10% |
| Cancer Cell Biology | 20 | 2 | 10% |
| Cardiovascular and Respiratory Diseases | 20 | 2 | 10% |
| Gene Regulation in Cancer | 20 | 2 | 10% |
| Hepatobiliary Pathophysiology | 20 | 2 | 10% |
| Immunity and Host Defense | 20 | 2 | 10% |
| Motor Function, Speech, and Rehabilitation | 20 | 2 | 10% |
| Pathophysiology of Obesity and Metabolic Disease | 20 | 2 | 10% |
| Pathogenic Eukaryotes | 20 | 2 | 10% |
| Environmental Determinants of Disease | 21 | 2 | 10% |
| Health Services: Quality and Effectiveness | 21 | 2 | 10% |
| Clinical Neuroplasticity and Neurotransmitters | 22 | 2 | 9% |
| Molecular Cancer Diagnosis and Classification | 22 | 2 | 9% |
| Skeletal Biology Development and Disease | 23 | 2 | 9% |
| Clinical Oncology | 24 | 2 | 8% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Molecular and Cellular Biology of Virus Infection | 15 | 1 | 7% |
| Anti-Infective Resistance and Targets | 16 | 1 | 6% |
| Cellular Immunotherapy of Cancer | 16 | 1 | 6% |
| HIV Coinfections and HIV-Associated Cancers | 16 | 1 | 6% |
| Macromolecular Structure and Function C | 16 | 1 | 6% |
| Neuroscience of Basic Visual Processes | 16 | 1 | 6% |
| Therapeutic Immune Regulation | 16 | 1 | 6% |
| Mechanisms of Cancer Therapeutics C | 17 | 1 | 6% |
| Skin and Connective Tissue Sciences | 17 | 1 | 6% |
| Therapeutic Development and Preclinical Studies | 17 | 1 | 6% |
| Basic Mechanisms in Cancer Health Disparities | 18 | 1 | 6% |
| Clinical Management in General Care Settings | 18 | 1 | 6% |
| Development - 2 | 18 | 1 | 6% |
| Organization and Delivery of Health Services | 18 | 1 | 6% |
| Pulmonary Vascular Disease and Physiology | 18 | 1 | 6% |
| Skeletal Muscle and Exercise Physiology | 18 | 1 | 6% |
| Viral Pathogenesis and Immunity | 18 | 1 | 6% |
| Adaptive Immunity | 19 | 1 | 5% |
| Bacterial Virulence | 19 | 1 | 5% |
| Community Influences on Health Behavior | 19 | 1 | 5% |
| Auditory System | 20 | 1 | 5% |
| Brain Injury and Neurovascular Disorders | 20 | 1 | 5% |
| Cancer Genetics | 20 | 1 | 5% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Drug Discovery and Molecular Pharmacology C | 20 | 1 | 5% |
| Etiology, Diagnostic, Intervention, and Treatment of Infectious Diseases | 20 | 1 | 5% |
| Biobehavioral Mechanisms of Emotion, Stress and Health | 20 | 1 | 5% |
| Molecular Neurogenetics | 20 | 1 | 5% |
| Pathophysiological Basis of Mental Disorders and Addictions | 20 | 1 | 5% |
| Social Psychology, Personality, and Interpersonal Processes | 20 | 1 | 5% |
| Tumor Host Interactions | 20 | 1 | 5% |
| Cellular and Molecular Biology of Glia | 21 | 1 | 5% |
| Clinical Translational Imaging Science | 21 | 1 | 5% |
| Drug and Biologic Therapeutic Delivery | 21 | 1 | 5% |
| Healthcare and Health Disparities | 21 | 1 | 5% |
| Chronic Dysfunction and Integrative Neurodegeneration | 22 | 1 | 5% |
| Clinical Data Management and Analysis | 22 | 1 | 5% |
| Emerging Imaging Technologies and Applications | 22 | 1 | 5% |
| Mechanisms of Autoimmunity | 22 | 1 | 5% |
| Mechanisms of Cancer Therapeutics A | 22 | 1 | 5% |
| Integrative Myocardial Physiology/Pathophysiology A | 22 | 1 | 5% |
| Advancing Therapeutics A | 23 | 1 | 4% |
| Biomaterials and Biointerfaces | 23 | 1 | 4% |
| Integrative Myocardial Physiology/Pathophysiology B | 23 | 1 | 4% |
| Population and Public Health Approaches to HIV/AIDS | 23 | 1 | 4% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Aging, Injury, Musculoskeletal, and Rheumatologic Disorders | 15 | 0 | 0% |
| Adult Lifespan Psychopathology | 17 | 0 | 0% |
| Aging Systems and Geriatrics | 20 | 0 | 0% |
| Analytics and Statistics for Population Research Panel A | 17 | 0 | 0% |
| Analytics and Statistics for Population Research Panel B | 13 | 0 | 0% |
| Biochemistry and Biophysics of Membranes | 18 | 0 | 0% |
| Basic Cancer Immunobiology | 10 | 0 | 0% |
| Biochemical and Cellular Oncogenesis | 19 | 0 | 0% |
| Biology and Development of the Eye | 20 | 0 | 0% |
| Biodata Management and Analysis | 20 | 0 | 0% |
| Brain Injury and Neurovascular Pathologies | 19 | 0 | 0% |
| Behavioral Neuroendocrinology, Neuroimmunology, Rhythms, and Sleep | 20 | 0 | 0% |
| Biobehavioral Regulation, Learning and Ethology | 13 | 0 | 0% |
| Bioengineering and Tissue Engineering for Neuroscience | 19 | 0 | 0% |
| Bioengineering, Technology and Surgical Sciences | 19 | 0 | 0% |
| Chemical Biology and Probes | 18 | 0 | 0% |
| Clinical Integrative Cardiovascular and Hematological Sciences | 17 | 0 | 0% |
| Cellular Mechanisms in Aging and Development | 21 | 0 | 0% |
| Cellular, Molecular, and Integrative Reproduction | 16 | 0 | 0% |
| Cellular and Molecular Biology of Neurodegeneration | 18 | 0 | 0% |
| Cellular and Molecular Technologies | 23 | 0 | 0% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Cancer Prevention | 17 | 0 | 0% |
| Chemical Synthesis and Biosynthesis | 18 | 0 | 0% |
| Cell Structure and Function-1 | 20 | 0 | 0% |
| Cellular Signaling and Regulatory Systems | 20 | 0 | 0% |
| Drug and Biologic Disposition and Toxicity | 15 | 0 | 0% |
| Drug Discovery and Molecular Pharmacology A | 20 | 0 | 0% |
| Drug Discovery and Molecular Pharmacology B | 20 | 0 | 0% |
| Enabling Bioanalytical and Imaging Technologies | 21 | 0 | 0% |
| Genomics, Computational Biology, and Technology | 20 | 0 | 0% |
| Genetic Variation and Evolution | 16 | 0 | 0% |
| Human Complex Mental Function | 19 | 0 | 0% |
| HIV/AIDS Intra- and Inter-Personal Determinants and Behavioral Interventions | 19 | 0 | 0% |
| HIV Immunopathogenesis and Vaccine Development | 15 | 0 | 0% |
| Health Promotion in Communities | 20 | 0 | 0% |
| HIV Molecular Virology, Cell Biology, and Drug Development | 19 | 0 | 0% |
| Integrative and Clinical Endocrinology and Reproduction | 12 | 0 | 0% |
| Imaging Guided Interventions and Surgery | 21 | 0 | 0% |
| Innovations in Nanosystems and Nanotechnology | 21 | 0 | 0% |
| Imaging Probes and Contrast Agents | 18 | 0 | 0% |
| Interventions to Prevent and Treat Addictions | 21 | 0 | 0% |
| Instrumentation and Systems Development | 22 | 0 | 0% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Imaging Technology Development | 22 | 0 | 0% |
| Imaging Technology for Neuroscience | 14 | 0 | 0% |
| Integrative Vascular Physiology and Pathology | 21 | 0 | 0% |
| Kidney, Endocrine, and Digestive Disorders | 11 | 0 | 0% |
| Language and Communication | 18 | 0 | 0% |
| Lifestyle and Health Behaviors | 11 | 0 | 0% |
| Learning, Memory, and Decision Neuroscience | 18 | 0 | 0% |
| Modeling and Analysis of Biological Systems | 19 | 0 | 0% |
| Molecular and Cellular Neuropharmacology | 16 | 0 | 0% |
| Molecular Genetics | 23 | 0 | 0% |
| Maximizing Investigators’ Research Award A | 14 | 0 | 0% |
| Maximizing Investigators’ Research Award B | 14 | 0 | 0% |
| Maximizing Investigators’ Research Award C | 15 | 0 | 0% |
| Maximizing Investigators’ Research Award D | 15 | 0 | 0% |
| Maximizing Investigators’ Research Award E | 12 | 0 | 0% |
| Maximizing Investigators’ Research Award F | 14 | 0 | 0% |
| Musculoskeletal Rehabilitation Sciences | 19 | 0 | 0% |
| Macromolecular Structure and Function A | 18 | 0 | 0% |
| Macromolecular Structure and Function B | 19 | 0 | 0% |
| Musculoskeletal Tissue Engineering | 20 | 0 | 0% |
| Neurotoxicology and Alcohol | 19 | 0 | 0% |
| Neuronal Communications | 20 | 0 | 0% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Neurodifferentiation, Plasticity, Regeneration, and Rhythmicity | 18 | 0 | 0% |
| Neuroscience of Interoception and Chemosensation | 13 | 0 | 0% |
| Neurobiology of Motivated Behavior | 21 | 0 | 0% |
| Neurological, Mental, and Behavioral Health | 20 | 0 | 0% |
| Neural Oxidative Metabolism, Mitochondria, and Cell Death | 23 | 0 | 0% |
| Neural Basis of Psychopathology, Addictions, and Sleep Disorders | 21 | 0 | 0% |
| Neurobiology of Pain and Itch | 19 | 0 | 0% |
| Oral, Dental, and Craniofacial Sciences | 19 | 0 | 0% |
| Prokaryotic Cell and Molecular Biology Study Section | 16 | 0 | 0% |
| Pathophysiology of Eye Disease 1 | 20 | 0 | 0% |
| Pathophysiology of Eye Disease 2 | 20 | 0 | 0% |
| Radiation Therapeutics and Biology | 24 | 0 | 0% |
| Skeletal Biology Structure and Regeneration | 22 | 0 | 0% |
| Social and Environmental Determinants of Health | 16 | 0 | 0% |
| Sensory–Motor Neuroscience | 15 | 0 | 0% |
| Social Sciences and Population Studies A | 17 | 0 | 0% |
| Social Sciences and Population Studies B | 17 | 0 | 0% |
| Tumor Evolution, Heterogeneity, and Metastasis | 18 | 0 | 0% |
| Translational Immuno-Oncology | 16 | 0 | 0% |
| Transmission of Vector-Borne and Zoonotic Diseases | 19 | 0 | 0% |
| Vaccines Against Infectious Diseases | 20 | 0 | 0% |
| Cognitive Disorder and Brain Aging | 7 | 0 | 0% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Standing Committee Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Clinical Neurodegeneration Translational Neuroscience | 25 | 0 | 0% |
| 3,459 | 204 | 6% |
NOTES: NIH = National Institutes of Health. The committee included study section members as having pediatrics expertise if their primary affiliation listed was with a department of pediatrics at a medical school or they were employed at a children’s hospital. This method excludes study section members who may have a secondary appointment or whose pediatric expertise is not otherwise evident and thus should be considered illustrative as opposed to a fully representative picture. The committee also did not have access to the number of pediatric-related applications in each study section and whether the applications reviewed in the study section required pediatric expertise. Additionally, the table does not include the count of ad hoc reviewers with pediatric expertise, so the percentage of reviewers with pediatric expertise on the study section may be slightly inexact. This table includes standing committee members participating in meetings for 1 year.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| NIH Director’s New Innovator Award Program | 229 | 11 | 5% |
| RFA-RM-24-004: NIH Director’s Transformative Research Awards | 176 | 11 | 6% |
| Member Conflict: Respiratory Sciences | 59 | 10 | 17% |
| Member Conflicts: Respiratory Topics | 59 | 10 | 17% |
| Member Conflicts: Pulmonary Diseases | 59 | 10 | 17% |
| NIH Director’s New Innovator Award Program (DP2) | 228 | 9 | 4% |
| RFA-RM-24-002: 2025 NIH Director’s Pioneer Award Review | 210 | 9 | 4% |
| Member Conflict: Topics in Urology and Nephrology | 66 | 9 | 14% |
| Member Conflict: Liver Diseases, Pharmacology and Toxicology | 66 | 9 | 14% |
| Member Conflict: Topics in Gastroenterology | 66 | 9 | 14% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Member Conflict: Cognition, Speech, Language, and Mental Health | 62 | 9 | 15% |
| Biobehavioral Mechanisms of Health | 62 | 9 | 15% |
| RFA-AR-24-007: HEAL Initiative - HEAL KIDS | 62 | 9 | 15% |
| Member Conflict: Topics in Biobehavioral Research | 62 | 9 | 15% |
| RFA Panel: NIH Director’s Early Independence Award Review | 188 | 7 | 4% |
| Advancing Therapeutics | 32 | 7 | 22% |
| Mechanisms of Autoimmunity and Inflammation | 48 | 6 | 13% |
| Member Conflict: Topics in Transplantation, Immunology, and Autoimmunity | 48 | 6 | 13% |
| Topics in Bacterial Pathogenesis and Molecular Host Interactions | 48 | 6 | 13% |
| PAR-23-064 Program Projects: Interactions Between HIV-1 and Opioids | 48 | 6 | 13% |
| Cardiovascular Differentiation and Development SEP | 23 | 6 | 26% |
| Cardiovascular Differentiation and Development | 23 | 6 | 26% |
| Topics in Health Services Research: Maternal, Reproductive, and Child Health and Substance Use | 38 | 5 | 13% |
| Member Conflict: Musculoskeletal Sciences | 57 | 4 | 7% |
| Member Conflict: Skeletal Muscle and Rehabilitation Sciences | 57 | 4 | 7% |
| Member Conflict: Skin, Oral, and Dental Sciences | 57 | 4 | 7% |
| PAR Panel: Fogarty Global Brain and Nervous System Disorders Research across the Lifespan | 51 | 4 | 8% |
| Member Conflict: Special Topics in Neural Disorders and Clinical Neuroscience | 38 | 4 | 11% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Nucleic Acid Therapeutic Delivery (NATD) | 40 | 3 | 8% |
| Topics in Health Services Research: Big Data, Health Information Technology, and Clinical Informatics | 39 | 3 | 8% |
| Topics in Clinical Data Management, Analysis, Informatics, and Digital Health A | 36 | 3 | 8% |
| Clinical Topics in Neuroimmunology and Neuroinflammation | 33 | 3 | 9% |
| RFA Panel: NIH Research Software Engineer (RSE) Award (R50) | 33 | 3 | 9% |
| Special Topics: Noninvasive Neuromodulation and Neuroimaging Technologies | 30 | 3 | 10% |
| Collaborative Applications: Clinical Studies of Mental Illness | 29 | 3 | 10% |
| Topics in Mechanisms of Autoimmunity | 19 | 3 | 16% |
| Special Topics in Psychosocial Development, Risk, and Prevention | 19 | 3 | 16% |
| Member Conflict: Bioengineering, Surgery, Anesthesiology, and Trauma | 61 | 2 | 3% |
| Member Conflict: Medical Imaging Investigations | 61 | 2 | 3% |
| Topics in Clinical Data Management, Analysis, Informatics, and Digital Health B | 45 | 2 | 4% |
| Member Conflict: Cancer Biology | 41 | 2 | 5% |
| Cancer Biology AREA/REAP Review | 41 | 2 | 5% |
| Member Conflict: Topics in Basic Neuroscience | 31 | 2 | 6% |
| Cellular and Molecular Aspects of the Blood–Brain Barrier and Neurovascular System and Therapeutic Strategies | 31 | 2 | 6% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Member Conflict: Hypertension and Thrombosis | 30 | 2 | 7% |
| Member Conflict: Atherosclerosis, Vascular Pathobiology, and Hematopoiesis | 30 | 2 | 7% |
| PAR-24-167 and PAR-24-259 Panel for R24 and S15 Instrumentation | 30 | 2 | 7% |
| Topics in Neurobehavior, Neuropsychology, and Neurodevelopment | 29 | 2 | 7% |
| Member Conflict: Immunity and Host Defense | 28 | 2 | 7% |
| Member Conflict: Disease Control and Applied Immunology | 28 | 2 | 7% |
| Special Topics in Transmission of Vector-Born and Zoonotic Diseases | 28 | 2 | 7% |
| IIA Innate Immunity A | 24 | 2 | 8% |
| PAR Panel: Innovative Research in Cancer Nanotechnology | 24 | 2 | 8% |
| Special Topics in Social Influences and Environmental Determinants of Health | 24 | 2 | 8% |
| Member Conflict: Topics in Endocrinology, Metabolism, and Reproductive Systems | 23 | 2 | 9% |
| Member Conflict: Health Services and Systems | 21 | 2 | 10% |
| RFA Panel: CounterACT Cooperative Agreements for Therapeutic Development and Basic Research on Chemical Threats Affecting the Nervous System | 20 | 2 | 10% |
| PAR Panel: Centers for Precision Disease Modeling (U54) | 19 | 2 | 11% |
| Societal and Ethical Issues in Research | 19 | 2 | 11% |
| RFA-NS-22-025: Helping to End Addiction Long-Term (HEAL) K99 | 12 | 2 | 17% |
| PAR: Enhancing Mechanistic Research on Precision Probiotic Therapies | 9 | 2 | 22% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Myalgic Encephalomyelitis–Chronic Fatigue Syndrome | 92 | 1 | 1% |
| Member Conflict: Auditory, Visual, and Cognitive Neuroscience | 92 | 1 | 1% |
| Member Conflict: Pain, Olfactory, and Sensorimotor Neuroscience | 92 | 1 | 1% |
| Member Conflict: Alcohol and Motivated Behavior | 92 | 1 | 1% |
| Member Conflict: Sleep, Rhythms, Social Behaviors, and Neuroimmunology | 92 | 1 | 1% |
| PAR Panel: Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions | 51 | 1 | 2% |
| Member Conflict: Topics in HIV Comorbidities, Coinfections, and Associated Cancers | 51 | 1 | 2% |
| Member Conflict: Topics in HIV Research | 51 | 1 | 2% |
| Training in Veterinary and Comparative Medicine | 43 | 1 | 2% |
| Member Conflict: Advancing Therapeutics | 43 | 1 | 2% |
| PAR Panel: Molecular and Cellular Underpinnings and Integrative Neuropathophysiology of Alzheimer’s Disease and Related Dementias (ADRD) | 39 | 1 | 3% |
| Special Topics: Bioanalytical, Molecular, and Cellular Sciences and Technologies | 38 | 1 | 3% |
| AREA/REAP: Musculoskeletal, Skin, and Oral Sciences | 38 | 1 | 3% |
| Neuroimmune, Neuroinflammation, and Metabolic Factors Involved in Neurodegenerative Disorders | 37 | 1 | 3% |
| Member Conflict: Cardiovascular Sciences | 35 | 1 | 3% |
| Special Topics in Bioengineering and Instrumentation | 32 | 1 | 3% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Infectious Disease Drug Development and Molecular Pharmacology | 32 | 1 | 3% |
| Member Conflict: Topics in Bacterial Virulence | 31 | 1 | 3% |
| Member Conflict: Topics in Pathogenic Eukaryotes | 31 | 1 | 3% |
| Neuro Informatics, Computational and Data Analysis | 31 | 1 | 3% |
| CSR Special Emphasis Panels | 29 | 1 | 3% |
| Member Conflict: Epidemiology and Population Health | 27 | 1 | 4% |
| PAR Panel: The NCI Transition and Community Oncology Career Development Awards, Institutional Research Training, Research Education Grants | 26 | 1 | 4% |
| PAR Panel: Intervention Research to Improve Native American Health | 26 | 1 | 4% |
| Member Conflict: Molecular Genetics | 25 | 1 | 4% |
| PAR Panel: Animal and Biological Material Resources and Centers | 25 | 1 | 4% |
| Immunology–Oncology | 24 | 1 | 4% |
| PAR: HIV/AIDS Behavioral Interventions and Health Outcomes | 21 | 1 | 5% |
| RFA-OD-23-017: Tobacco Regulatory Science Panel A | 21 | 1 | 5% |
| Human Genetics and Genomics Topics | 20 | 1 | 5% |
| Member Conflict: Bioengineering, Biodata, and Biomodelling Technologies | 18 | 1 | 6% |
| Research Enhancement Awards: Cell and Molecular Biology | 18 | 1 | 6% |
| PAR-23-281: Research Projects to Enhance Applicability of Mammalian Models for Translational Research | 18 | 1 | 6% |
| Innate Immunity A | 18 | 1 | 6% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Member Conflict: Neurotechnology and Vision | 18 | 1 | 6% |
| Biology of Aging | 17 | 1 | 6% |
| Member Conflict: Topics in Adaptive and Innate Immunity | 13 | 1 | 8% |
| RFA-OD-25-002: Investigation of Co-Occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) | 6 | 1 | 17% |
| Special Topics: Pathophysiology of Eye Disease | 5 | 1 | 20% |
| Clinical Care and Health Interventions | 72 | 0 | 0% |
| RFA-OD-23-017: Tobacco Regulatory Science (TRS) | 72 | 0 | 0% |
| Substance Use and Prevention and Treatment of Addiction | 72 | 0 | 0% |
| RFA-NS-24-021: HEAL Initiative—Understanding Individual Differences in Human Pain Conditions | 72 | 0 | 0% |
| Topics in Health Services Research, Aging, and Workforce Issues | 43 | 0 | 0% |
| PAR Panel: Metabolic, Cerebrovascular, Environmental, and Sleep Factors in Alzheimer’s Disease and Related Dementias (ADRD) | 36 | 0 | 0% |
| Imaging and Bioengineering Technology for Visual Systems (IBV) | 36 | 0 | 0% |
| Special Topics in Biodata Management and Analysis | 35 | 0 | 0% |
| RFA Panel: Building Sustainable Software Tools for Open Science (R03) B | 34 | 0 | 0% |
| RFA Panel: Building Sustainable Software Tools for Open Science (R03) A | 33 | 0 | 0% |
| PAR Panel: Topics in Neurodegeneration and Brain Injury | 29 | 0 | 0% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Collaborative Applications: Clinical Studies of Mental Illness | 28 | 0 | 0% |
| PAR Panel: Maximizing Investigators’ Research Award (R35) | 28 | 0 | 0% |
| PAR-23-145: Maximizing Investigators’ Research Award (MIRA) for Early-Stage Investigators | 27 | 0 | 0% |
| Topics in Bacterial-Host Interactions | 26 | 0 | 0% |
| Special Topics in Community-Level Interventions and Prevention Research | 25 | 0 | 0% |
| RFA-NS-23-023: BRAIN Initiative: Targeted BRAIN Circuits Planning Projects | 24 | 0 | 0% |
| Special Topics in Biomaterials, Nanoscience, and Drug Delivery | 23 | 0 | 0% |
| Member Conflict: Cell Signaling, Structure, and Function | 22 | 0 | 0% |
| Member Conflict: Developmental Biology | 22 | 0 | 0% |
| Member Conflict: Biology of the Eye | 22 | 0 | 0% |
| Psychosocial Risk and Interpersonal Processes of Health | 22 | 0 | 0% |
| PAR Panel: International and Cooperative Projects for the Emerging Global Leader Award | 21 | 0 | 0% |
| Member Conflict: Macromolecular Biophysics and Biochemistry | 20 | 0 | 0% |
| Special Topics in Social Sciences and Population Studies | 20 | 0 | 0% |
| Special Topics in Health Interventions and Public Health Approaches in HIV/AIDS | 19 | 0 | 0% |
| PAR Panel: The Cellular and Molecular Biology of Complex Brain Disorders | 17 | 0 | 0% |
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
| Study Section Description | No. of Panel Members | No. of Pediatrics-Specific Members | Percentage |
|---|---|---|---|
| Special Topics in Brain and Neural Injury | 17 | 0 | 0% |
| Member Conflict: Applied Immunology and Disease Control | 17 | 0 | 0% |
| Member Conflict: Neurodegeneration | 16 | 0 | 0% |
| Imaging Guided Interventions and Surgery | 14 | 0 | 0% |
| USU—Center for Health Services Research | 14 | 0 | 0% |
| Special Topics in Transmission of Vector-Borne and Zoonotic Diseases | 13 | 0 | 0% |
| RFA-NS-22-034: HEAL Initiative | 13 | 0 | 0% |
| Mature Synchrotron Resources for Structural Biology | 11 | 0 | 0% |
| Academic Research Enhancement Awards | 10 | 0 | 0% |
| Topics in Etiology, Diagnostic, Intervention, and Treatment of Infectious Diseases | 9 | 0 | 0% |
| 5,702 | 324 | 6% |
NOTES: AREA = Academic Research Enhancement Award; CSR = Center for Scientific Review; NCI = National Cancer Institute; NIH = National Institutes of Health; PAR = Program Announcement with special receipt, referral and/or review considerations; REAP = Research Enhancement Award Program; RFA = Request for Applications ; USU = Uniformed Services University. Special emphasis panels may use aggregate rosters, which can skew the proportion of reviewers with pediatric expertise, as these rosters include reviewers from various panels. This table includes panel members participating in one meeting occurrence.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Suggested Citation:
"Appendix G: Pediatric Representation on Scientific Review." National Academies of Sciences, Engineering, and Medicine. 2026. Strategies to Enhance NIH-Funded Pediatric Research: Optimizing Child Health. Washington, DC: The National Academies Press.
doi: 10.17226/29346.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.